The emerging treatment of the medication represents a major development in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide targets dual pathways – GLP-1 and the GIP hormone https://tirzepatidepeptide082913.blue-blogs.com/50278102/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment